Literature DB >> 16844867

Is warfarin a contraindication to thrombolysis in acute ST elevation myocardial infarction?

A G Stanley, S Fletcher, A Tan, D B Barnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16844867      PMCID： PMC1861091          DOI： 10.1136/hrt.2005.062158

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  4 in total

1.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

2.  Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors.

Authors:  P P De Jaegere; A A Arnold; A H Balk; M L Simoons
Journal:  J Am Coll Cardiol       Date:  1992-02       Impact factor: 24.094

3.  Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

Authors:  J M Gore; C B Granger; M L Simoons; M A Sloan; W D Weaver; H D White; G I Barbash; F Van de Werf; P E Aylward; E J Topol
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

4.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
  4 in total
  4 in total

1.  Anticoagulation in ischaemic heart disease.

Authors:  R De Cristofaro
Journal:  Heart       Date:  2006-08       Impact factor: 5.994

Review 2.  Optimizing the use of thrombolytics in ST-segment elevation myocardial infarction.

Authors:  Michael A Morse; Josh W Todd; George A Stouffer
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

3.  Use of intravenous recombinant tissue plasminogen activator in patients with borderline elevation of international normalized ratio.

Authors:  Harsh R Aggarwal; Ameer E Hassan; Gustavo J Rodriguez; M Fareed K Suri; Robert A Taylor; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2013-12

4.  Warfarin and fibrinolysis--a challenging combination: an observational cohort study.

Authors:  Sini Saarinen; Jyrki Puolakka; James Boyd; Taneli Väyrynen; Harri Luurila; Markku Kuisma
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2011-04-05       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.